Spear Bio

Ultra-Sensitive Biomarker Detection

Boston, United States · Founded 2021 · $45.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Website
spear.bio
Total Funding
$45.0M
Last Round
$45.0M Series AJul 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Spear Bio develops ultra-sensitive immunoassay kits and services based on its patented SPEAR (Successive Proximity Extension Amplification Reaction) technology. The wash-free, homogeneous platform detects protein biomarkers at attomolar concentrations using 1 µL or less of sample and a standard qPCR workflow, enabling research in neurological diseases including Alzheimer's, TBI, multiple sclerosis, and ALS.

Summary

Spear Bio is a Biotech company based in Boston, United States, founded in 2021. It has raised $45.0M in total across 3 rounds, most recently a $45.0M Series A round in Jul 2024. Investors include Maverick Ventures, CDH Investments and Foresite Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJul 2024
$45.0M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Spear Bio on Indexed.vc
<a href="https://indexed.vc/companies/spear-bio"><img src="https://indexed.vc/api/badge/company/spear-bio" alt="Spear Bio on Indexed.vc" width="260" height="76" /></a>